235 related articles for article (PubMed ID: 28842709)
1. The Parkinson's disease-associated GPR37 receptor interacts with striatal adenosine A
Morató X; Luján R; López-Cano M; Gandía J; Stagljar I; Watanabe M; Cunha RA; Fernández-Dueñas V; Ciruela F
Sci Rep; 2017 Aug; 7(1):9452. PubMed ID: 28842709
[TBL] [Abstract][Full Text] [Related]
2. Chronic adenosine A
Morató X; Gonçalves FQ; Lopes JP; Jauregui O; Soler C; Fernández-Dueñas V; Cunha RA; Ciruela F
J Neurochem; 2019 Mar; 148(6):796-809. PubMed ID: 30578680
[TBL] [Abstract][Full Text] [Related]
3. The role of parkinson's disease-associated receptor GPR37 in the hippocampus: functional interplay with the adenosinergic system.
Lopes JP; Morató X; Souza C; Pinhal C; Machado NJ; Canas PM; Silva HB; Stagljar I; Gandía J; Fernández-Dueñas V; Luján R; Cunha RA; Ciruela F
J Neurochem; 2015 Jul; 134(1):135-46. PubMed ID: 25824528
[TBL] [Abstract][Full Text] [Related]
4. Adenosine A2A receptor-mediated control of pilocarpine-induced tremulous jaw movements is Parkinson's disease-associated GPR37 receptor-dependent.
Gandía J; Morató X; Stagljar I; Fernández-Dueñas V; Ciruela F
Behav Brain Res; 2015 Jul; 288():103-6. PubMed ID: 25862943
[TBL] [Abstract][Full Text] [Related]
5. Allosteric Interactions between Adenosine A
Prasad K; de Vries EFJ; Elsinga PH; Dierckx RAJO; van Waarde A
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572077
[TBL] [Abstract][Full Text] [Related]
6. The mGlu
Romero-Fernandez W; Taura JJ; Crans RAJ; Lopez-Cano M; Fores-Pons R; Narváez M; Carlsson J; Ciruela F; Fuxe K; Borroto-Escuela DO
Mol Neurobiol; 2022 Oct; 59(10):5955-5969. PubMed ID: 35829830
[TBL] [Abstract][Full Text] [Related]
7. Revealing Adenosine A
Fernández-Dueñas V; Gómez-Soler M; Valle-León M; Watanabe M; Ferrer I; Ciruela F
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31340557
[No Abstract] [Full Text] [Related]
8. Neuroprotection by caffeine in the MPTP model of parkinson's disease and its dependence on adenosine A2A receptors.
Xu K; Di Luca DG; Orrú M; Xu Y; Chen JF; Schwarzschild MA
Neuroscience; 2016 May; 322():129-37. PubMed ID: 26905951
[TBL] [Abstract][Full Text] [Related]
9. GPR37 associates with the dopamine transporter to modulate dopamine uptake and behavioral responses to dopaminergic drugs.
Marazziti D; Mandillo S; Di Pietro C; Golini E; Matteoni R; Tocchini-Valentini GP
Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9846-51. PubMed ID: 17519329
[TBL] [Abstract][Full Text] [Related]
10. Rescue of locomotor impairment in dopamine D2 receptor-deficient mice by an adenosine A2A receptor antagonist.
Aoyama S; Kase H; Borrelli E
J Neurosci; 2000 Aug; 20(15):5848-52. PubMed ID: 10908627
[TBL] [Abstract][Full Text] [Related]
11. Remote control of movement disorders using a photoactive adenosine A
Taura J; Nolen EG; Cabré G; Hernando J; Squarcialupi L; López-Cano M; Jacobson KA; Fernández-Dueñas V; Ciruela F
J Control Release; 2018 Aug; 283():135-142. PubMed ID: 29859955
[TBL] [Abstract][Full Text] [Related]
12. Induction of macroautophagy by overexpression of the Parkinson's disease-associated GPR37 receptor.
Marazziti D; Di Pietro C; Golini E; Mandillo S; Matteoni R; Tocchini-Valentini GP
FASEB J; 2009 Jun; 23(6):1978-87. PubMed ID: 19218498
[TBL] [Abstract][Full Text] [Related]
13. Mice lacking the Parkinson's related GPR37/PAEL receptor show non-motor behavioral phenotypes: age and gender effect.
Mandillo S; Golini E; Marazziti D; Di Pietro C; Matteoni R; Tocchini-Valentini GP
Genes Brain Behav; 2013 Jun; 12(4):465-77. PubMed ID: 23574697
[TBL] [Abstract][Full Text] [Related]
14. Motor Deficits Coupled to Cerebellar and Striatal Alterations in Ube3a
Moreira-de-Sá A; Gonçalves FQ; Lopes JP; Silva HB; Tomé ÂR; Cunha RA; Canas PM
Mol Neurobiol; 2021 Jun; 58(6):2543-2557. PubMed ID: 33464534
[TBL] [Abstract][Full Text] [Related]
15. CD73-derived adenosine controls inflammation and neurodegeneration by modulating dopamine signalling.
Meng F; Guo Z; Hu Y; Mai W; Zhang Z; Zhang B; Ge Q; Lou H; Guo F; Chen J; Duan S; Gao Z
Brain; 2019 Mar; 142(3):700-718. PubMed ID: 30689733
[TBL] [Abstract][Full Text] [Related]
16. G-protein coupled receptor 6 deficiency alters striatal dopamine and cAMP concentrations and reduces dyskinesia in a mouse model of Parkinson's disease.
Oeckl P; Hengerer B; Ferger B
Exp Neurol; 2014 Jul; 257():1-9. PubMed ID: 24747358
[TBL] [Abstract][Full Text] [Related]
17. PET Imaging of the Adenosine A
Schröder S; Lai TH; Toussaint M; Kranz M; Chovsepian A; Shang Q; Dukić-Stefanović S; Deuther-Conrad W; Teodoro R; Wenzel B; Moldovan RP; Pan-Montojo F; Brust P
Molecules; 2020 Apr; 25(7):. PubMed ID: 32252340
[TBL] [Abstract][Full Text] [Related]
18. The Parkinson's disease-associated GPR37 receptor-mediated cytotoxicity is controlled by its intracellular cysteine-rich domain.
Gandía J; Fernández-Dueñas V; Morató X; Caltabiano G; González-Muñiz R; Pardo L; Stagljar I; Ciruela F
J Neurochem; 2013 May; 125(3):362-72. PubMed ID: 23398388
[TBL] [Abstract][Full Text] [Related]
19. Parkinson's disease-associated GPR37 receptor regulates cocaine-mediated synaptic depression in corticostriatal synapses.
Rial D; Morató X; Real JI; Gonçalves FQ; Stagljar I; Pereira FC; Fernández-Dueñas V; Cunha RA; Ciruela F
Neurosci Lett; 2017 Jan; 638():162-166. PubMed ID: 28007645
[TBL] [Abstract][Full Text] [Related]
20. GPR88 in A2AR Neurons Enhances Anxiety-Like Behaviors.
Meirsman AC; Robé A; de Kerchove d'Exaerde A; Kieffer BL
eNeuro; 2016; 3(4):. PubMed ID: 27570825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
